MEA Hyaluronic Acid Products Market

MEA Hyaluronic Acid Products Market Size (2024 to 2029)

The size of the Hyaluronic Acid Products market in the Middle East and Africa was around USD 0.86 Billion in 2024. It is expected to grow at a CAGR of 6.5% to reach USD 1.18 billion by 2029.

The growth of the MEA hyaluronic acid products market is increasing for the aging population due to the increasing prevalence of osteoarthritis, ophthalmic plastic surgeries, and derma-fillers. Hence the growing rate of the senior population, increased awareness of hyaluronic acid products in the MEA region are driving the market. According to the WHO, the world's population over 60 will double from 13% to 23% from 2015-2050. Between 2020 and 2050, Africa's elderly population is expected to triple from 74.8 million to 237.7 million. Its growth over the next three decades is estimated to exceed that of any other region in the world. According to a recent study, the total population of senior Saudis was estimated at 859,500, representing 5.4% of the total population of Saudi citizens. Saudi Arabia is one of the largest economies in the Middle East region, with growing demand for generics and the growing expansion of international players in the country have enabled substantial growth in the pharmaceutical industry to produce hyaluronic acid products.

The demand for hyaluronic acid products will increase as bone-related issues are likely to be at their highest in the coming years, coupled with the need for minimally invasive procedures, which is expected to drive market growth. Hyaluronic acid is available in the form of dietary supplements, pills, injections in the market for people who have low levels of hyaluronic acid in their bodies. Glycosaminoglycan are rich in hyaluronic acid helps to alleviate inflammatory conditions; hence they use extensively in the medical sector. Hyaluronic acid is used as injectable filler to smooth age-related wrinkles, hide recessed scars, and increase and define the contours of the face and other body areas. It is also commonly used in skin care products to provide softer, hydrated, and radiant skin due to its moisture-retaining characteristics. Moreover, the constant evolution in healthcare technology and an increase in R&D activities lead to the development of the MEA hyaluronic acid products market.

However, several factors are responsible for restraining the MEA hyaluronic acid products market, such as high price, poor healthcare awareness due to inadequate medical facilities, side effects of hyaluronic acid use like itchiness, soreness, redness, and discoloration, etc.

This research report on the MEA hyaluronic acid products market has been segmented and sub-segmented into the following categories

MEA Hyaluronic Acid Products Market By Product Type

• Single Cycle Injection Products
• Three Cycle Injection Projects
• Five Cycle Injection Products

MEA Hyaluronic Acid Products Market By Application

• Osteoarthritis
• Ophthalmic
• Dermal Fillers
• Vesicoureteral Reflux

MEA Hyaluronic Acid Products Market By Country

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Over the forecast period, the Middle East region is expected to dominate the MEA market. Countries in the Middle East and Africa are emerging as attractive outsourcing destinations for the pharmaceutical and biopharmaceutical industries to increase the production rate. The aging population of the UAE will likely increase the hyaluronic acid products in the UAE. In 2018, the Dubai Health Authority reported that the local elderly population would go from 7% to 30% by 2050. Additionally, the booming domestic pharmaceutical market, growing research and development sector, and high rate of cosmetic procedures will drive the sale numbers in the region. Osteoarthritis is one of the leading causes of disability in the UAE, with around 52% of the senior population is suffering from chronic conditions. About 26% of people over 60 suffer from severe pain and disability caused by osteoarthritis, providing market growth opportunities for hyaluronic acid products in the years to come.

In 2023, Saudi Arabia had a high CAGR of 7% for the studied market. This market growth can be attributed to the increase in the aging population, a well-developed pharmaceutical industry, and the high production of drugs. These factors are expected to positively impact the Saudi Arabia hyaluronic acid products market during the forecast period.

KEY MARKET PLAYERS

Allergan, Sanofi, Ferring B.V., Zimmer Biomet, Fidia Farmceutici, Salix Pharmaceutical, Anika Therapeutics, Seikagaku Corporation, Hoffmann-LA Roche Ltd, Alcon, Inc., Smith & Nephew plc and F.Merz Asthetics, Inc. are expected to play a leading role in the MEA hyaluronic acid products market during the forecast period.